

Author: Krymchantowski A.V.
Publisher: Adis International
ISSN: 1172-7047
Source: CNS Drugs, Vol.16, Iss.9, 2002-01, pp. : 611-634
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Treatment of migraine with prophylactic drugs
By Evers Stefan
Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. :


Clinical Potential of Emerging New Agents in Hepatitis B
By Farrell G.C.
Drugs, Vol. 60, Iss. 4, 2000-10 ,pp. :


Emerging drugs in migraine treatment
Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. :


Prophylactic nadolol or topiramate boosts QOL in migraine
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 537, 2007-01 ,pp. :